Evidence map›Paper›PMID 33758424›Full record

ArticleNature metabolism2021

STK3/STK4 signalling in adipocytes regulates mitophagy and energy expenditure.

Yoon Keun Cho, Yeonho Son, Abhirup Saha, Doeun Kim, Cheoljun Choi, Minsu Kim, Ji-Hyun Park, Hyeonyeong Im, Juhyeong Han, Kyungmin Kim and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. MTCH2 Suppresses Thermogenesis by Regulating Autophagy in Adipose Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Yoon Keun Cho *College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Yeonho Son *College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Abhirup Saha *College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Doeun Kim *BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea.
Cheoljun ChoiCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.ORCID http://orcid.org/0000-0002-1890-4660
Minsu KimCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Ji-Hyun ParkCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Hyeonyeong ImCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Juhyeong HanCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Kyungmin KimCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Young-Suk JungCollege of Pharmacy, Pusan National University, Busan, Republic of Korea.
Jeanho YunDepartment of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Republic of Korea.ORCID http://orcid.org/0000-0001-7700-5123
Eun Ju BaeCollege of Pharmacy, Chonbuk National University, Jeonju, Republic of Korea.
Je Kyung SeongLaboratory of Developmental Biology and Genomics, BK21 Plus Program for Advanced Veterinary Science, Research Institute for Veterinary Science, College of Veterinary Medicine, and Korea Mouse Phenotyping Center, Seoul National University, Seoul, Republic of Korea.
Mi-Ock LeeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Sangkyu LeeBK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea.ORCID http://orcid.org/0000-0001-5343-701X
James G GrannemanCenter for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.ORCID http://orcid.org/0000-0001-7013-6630
Yun-Hee LeeCollege of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. yunhee.lee@snu.ac.kr.ORCID http://orcid.org/0000-0002-0542-4705
Seoul National University · KRKyungpook National University · KRDong-A University · KRJeonbuk National University · KRPusan National University · KRWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity reduces adipocyte mitochondrial function, and expanding adipocyte oxidative capacity is an emerging strategy to improve systemic metabolism. Here, we report that serine/threonine-protein kinase 3 (STK3) and STK4 are key physiological suppressors of mitochondrial capacity in brown, beige and white adipose tissues. Levels of STK3 and STK4, kinases in the Hippo signalling pathway, are greater in white than brown adipose tissues, and levels in brown adipose tissue are suppressed by cold exposure and greatly elevated by surgical denervation. Genetic inactivation of Stk3 and Stk4 increases mitochondrial mass and function, stabilizes uncoupling protein 1 in beige adipose tissue and confers resistance to metabolic dysfunction induced by high-fat diet feeding. Mechanistically, STK3 and STK4 increase adipocyte mitophagy in part by regulating the phosphorylation and dimerization status of the mitophagy receptor BNIP3. STK3 and STK4 expression levels are elevated in human obesity, and pharmacological inhibition improves metabolic profiles in a mouse model of obesity, suggesting STK3 and STK4 as potential targets for treating obesity-related diseases.

Indexed as

Energy MetabolismMitophagySignal TransductionAdipocytesAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsCell LineHippo KinasesHumansIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutObesityProtein Serine-Threonine KinasesSerine-Threonine Kinase 3Hippo KinasesIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesSerine-Threonine Kinase 3STK3 protein, humanSTK4 protein, human

Identifiers

PMID33758424
OpenAlexW3136945729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.